News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Endogenous human microRNAs that suppress breast cancer metastasis
A set of microRNAs were discovered to be general regulators of cancer metastasis. Scientist from the Memorial Sloan-Kettering Cancer Center in New York (USA) now demonstrated, how restoring the expression of these microRNAs in malignant cells can suppress lung and bone metastasisation of human cancer cells in vivo.
Of the microRNAs, miR-335 suppresses metastasis and migration by targeting the progenitor cell transcription factor SOX4 and extracellular matrix component tenascin C. miR-126 reduces tumour growth and proliferation. The Expression of miR-335 and miR-126 is lost in most primary breast tumours of relapsing cancer patients. Loss of either microRNA is linked to poor survival.
The microRNAs miR-335 and miR-126 are therefore metastasis suppressors of human breast cancer.
Related antibodies on antibodies-online.com:
Antibodies for the research area oncology: »Show antibodies
Antibodies for the research area RNA: »Show antibodies
-

13.11.2008 Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress -

13.11.2008 Effective induction of high-titer antibodies by viral vector vaccines -

03.11.2008 Y-box-1 protein (Yb-1) and breast cancer: Prognostic factor and target for therapy -

28.10.2008 NALP3 inflammasome is involved in the innate immune response to amyloid-beta -

28.10.2008 Adenovirus Small e1a Alters Global Patterns of Histone Modification -

28.10.2008 Plant Immunity Requires Conformational Charges of NPR1 via S-Nitrosylation and Thioredoxins -

28.10.2008 The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine -

09.10.2008 Autophagy Is Essential for Preimplantation Development of Mouse Embryos -

09.10.2008 Modulation of Gene Expression via Disruption of NF-kappa-B Signaling by a Bacterial Small Molecule -

09.10.2008 Anomalous Type 17 Response to Viral Infection by CD8+ T Cells Lacking T-bet and Eomesodermin







